Scientists test 'Ready-Made' cell therapy in major push against incurable blood cancer

NCT ID NCT04960579

Recruiting now Disease control Sponsor: Poseida Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This early-stage trial is testing the safety of a new type of cell therapy called P-BCMA-ALLO1 in adults with multiple myeloma that has come back or stopped responding to standard treatments. The therapy uses genetically modified immune cells from a donor, not the patient, aiming for an 'off-the-shelf' treatment. Researchers will give the therapy at different doses to find the safest and most effective amount.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Advocate Aurora Health
TERMINATED

Park Ridge, Illinois, 66068, United States
Blood Marrow and Transplant Group of Georgia
RECRUITING

Atlanta, Georgia, 30342, United States
City of Hope
RECRUITING

Goodyear, Arizona, 85338, United States
City of Hope
RECRUITING

Chicago, Illinois, 60099, United States
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States
Emory University
RECRUITING

Atlanta, Georgia, 30322, United States
Hackensack Meridian Health
NOT_YET_RECRUITING

Hackensack, New Jersey, 07601, United States
Houston Methodist Research Institute
RECRUITING

Houston, Texas, 77030, United States
Mount Sinai
NOT_YET_RECRUITING

New York, New York, 10029, United States
Roswell Park Comprehensive Cancer Center
RECRUITING

Buffalo, New York, 14263, United States
Sarah Cannon Research Institute - Methodist Healthcare
RECRUITING

San Antonio, Texas, 78229, United States
Sarah Cannon Research Institute - St. David's South Austin Medical Center
RECRUITING

Austin, Texas, 78704, United States
University of California San Diego
RECRUITING

San Diego, California, 92093, United States
University of California San Francisco
TERMINATED

San Francisco, California, 94143, United States
University of Cincinnati
RECRUITING

Cincinnati, Ohio, 45221, United States
University of Iowa
RECRUITING

Iowa City, Iowa, 52242, United States
University of Kansas Medical Center
ACTIVE_NOT_RECRUITING

Kansas City, Kansas, 66160, United States
University of Maryland Greenebaum Comprehensive Cancer Center
RECRUITING

Baltimore, Maryland, 21201, United States
University of North Carolina at Chapel Hill
RECRUITING

Chapel Hill, North Carolina, 27599-1350, United States
University of Oklahoma, Health Sciences Center
RECRUITING

Oklahoma City, Oklahoma, 73104, United States
University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104-4238, United States
Vanderbilt University Medical Center
RECRUITING

Nashville, Tennessee, 37232, United States
Wayne State - Karmanos Cancer Institute
RECRUITING

Detroit, Michigan, 48201, United States

Conditions

Explore the condition pages connected to this study.

MULTIPLE MYELOMA